Levonelle

Levonorgestrel, the active ingredient in Levonelle, is a progestogen presented as an oral tablet for emergency contraception use. It works to prevent ovulation and may inhibit fertilisation or implantation, providing a post‑coital option for preventing unintended pregnancy in women of reproductive age.

GNH USA supplies Levonelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. Clients benefit from consistent product availability, regulatory compliance support, and responsive technical assistance.

Levonorgestrel is a progestogenic agent used primarily in the hormonal pathway of emergency contraception and short‑term pregnancy prevention. - Emergency contraception: Provides a post‑coital option to prevent unintended pregnancy when taken within the recommended time frame. - Prevention of pregnancy: Used as a single‑dose regimen to reduce the risk of conception after unprotected intercourse. - Hormonal contraception component: Serves as the progestin component in combined oral contraceptives for regular birth control.

Levonelle may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Abdominal pain or cramps: discomfort in the lower abdomen. - Headache: transient tension‑type headache. - Dizziness or light‑headedness. - Fatigue or general weakness. - Menstrual changes: spotting, early or delayed bleeding.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: may indicate ectopic pregnancy. - Chest pain or palpitations. - Persistent vomiting or dehydration. - Thromboembolic events: rare clotting disorders. - Severe headache with visual disturbances.

Before using Levonelle, consider the following safety measures. - Assess timing of unprotected intercourse: ensure product is taken within 72‑120 hours for optimal efficacy. - Consider body weight/BMI: efficacy may be reduced in individuals with BMI >30 kg/m². - Review concomitant medications: enzyme inducers can lower effectiveness. - Avoid use in known hypersensitivity to levonorgestrel or tablet excipients. - Pregnancy testing not required before use, but confirm the patient is not already pregnant. Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Levonelle can interact with other medicines, affecting its effectiveness.

Major Interactions (Avoid): - Rifampicin and other strong enzyme inducers: may significantly reduce efficacy. - Anticonvulsants such as phenytoin or carbamazepine: may lower effectiveness.

Moderate Interactions (Monitor Closely): - St. John’s wort: may modestly reduce efficacy. - Protease inhibitor antiretrovirals: potential interaction, monitor clinical response. - Concurrent hormonal contraceptives: may increase overall hormonal exposure; watch for side‑effects.